Oral Oncology
Volume 40, Issue 1 , Pages 13-20, January 2004

Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma

Department of Oral and Maxillofacial Surgery, Ehime University School of Medicine, 454 Shitsukawa, Shigenobu-cho, Onsen-gun, Ehime, 791-0295 Japan

Received 13 May 2003; accepted 27 May 2003.

Abstract 

Vascular endothelial growth factor (VEGF) A is known to play an important role in tumor angiogenesis. The additional members of the VEGF family, VEGF B, C and D have been discovered. VEGF C and D show some selectivity toward lymphatic endothelial cells. However, whether VEGF family members play a role in tumor angiogenesis and lymph node metastasis is largely unknown. The aim of the present study was to explore the role of VEGF family members in oral squamous cell carcinoma (OSCC). We evaluated the expression of VEGF family members by immunohistochemistry, reverse transcription–polymerase chain reaction, and western blotting. All VEGF members were expressed at different levels in OSCC. Immunohistological analysis of VEGF family members expression and microvessel density revealed a correlation between VEGF A and B expression and tumor angiogenesis. Although VEGF A and B expression were detected in both node-positive and node-negative OSCC, VEGF C and D expression was detected frequently in node-positive tumors compared to node-negative tumors. These findings suggest a possible relationship between the expression level of VEGF C and/or D and development of lymphatic tumor spread.

Keywords:  Vascular endothelial growth factor, Angiogenesis, Lymph node metastasis, Oral squamous cell carcinoma

Abbreviations:  VEGF, vascular endothelial growth factor, OSCC, oral squamous cell carcinomas, MVD, microvessel density, RT–PCR, reverse transcription–polymerase chain reaction, SD, standard deviation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(03)00127-1

doi:10.1016/S1368-8375(03)00127-1

Oral Oncology
Volume 40, Issue 1 , Pages 13-20, January 2004